ArticleCureus2026
Movement-Provoked Paroxysmal Neuralgia Following Longitudinally Extensive Transverse Myelitis in Neuromyelitis Optica Spectrum Disorder: A Presumed Ephaptic Spinal Cord Phenomenon.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Neuromyelitis optica spectrum disorder (NMOSD) is an autoimmune astrocytopathy frequently complicated by neuropathic pain. Paroxysmal symptoms likely arise from ephaptic transmission within demyelinated spinal cord tracts and are underdescribed when presenting as isolated sensory phenomena, unlike the well-characterized tonic spasms. We report a 76-year-old woman with aquaporin-4 (AQP4) antibody-positive NMOSD recovering from her first disease flare, which initially manifested as longitudinally extensive transverse myelitis (LETM). Weeks later, she developed sudden, excruciating, movement-provoked paroxysmal burning pain in the lower extremities. Episodes lasted 4-8 seconds and occurred approximately 20 times daily. Serial neurologic examinations revealed no new deficits suggestive of relapse, and repeat MRI was deferred as relapse was considered clinically unlikely. Symptoms were refractory to gabapentin but improved dramatically within 24 hours of initiating oxcarbazepine 300 mg twice daily. The clinical phenotype and rapid response to sodium channel blockade support a sodium channel-mediated mechanism, most likely ephaptic transmission, rather than trigger-independent ectopic firing, which remains sparsely described in the literature. Recognition of this phenomenon is crucial to avoid misclassification as relapse, unnecessary imaging, and unwarranted escalation of immunotherapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.